Resorcinol derivatives

Details Resorcinol derivatives Resorcinol derivatives

2007-10-16

2007-10-16

Anderson, Rebecca (Department: 1626)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C514S385000, C514S386000, C548S316400, C548S325100

Reexamination Certificate

active

11562271

ABSTRACT:
The present invention relates to certain resorcinol derivatives and their use as skin lightening agents.

REFERENCES:
patent: 4526179 (1985-07-01), Salesky
patent: 4959393 (1990-09-01), Torihara et al.
patent: 5449518 (1995-09-01), Junino et al.
patent: 5508155 (1996-04-01), Marrese et al.
patent: 5580549 (1996-12-01), Fukuda et al.
patent: 6123959 (2000-09-01), Jones et al.
patent: 6132740 (2000-10-01), Hu
patent: 6159482 (2000-12-01), Tuloup et al.
patent: 6590105 (2003-07-01), Bradley et al.
patent: 6852747 (2005-02-01), Bradley et al.
patent: 2005/0282899 (2005-12-01), Bradley et al.
patent: 0 904 774 (1999-03-01), None
patent: WO 99/12474 (1999-03-01), None
patent: WO 00/56702 (2000-09-01), None
PCT International Search Report, PCT/IB01/01605.
Beavo, “Cyclic Nucleotide Phosphodiesterase: Functional Implications of Multiple Isoforms”, Physiological Reviews, vol. 75, No. 4, 1995, pp. 725-748.
Fink et al., Expression of an Active, Monomeric Catalytic Domain of the cGMP-binding cGMP-specific Phosphodiesterase (PDE5), J. Biol. Chem., vol. 274, No. 49, 1999, pp. 34613-34620.
Lim et al., “Activation of the cAMP-specific Phosphodiesterase PDE4D3 by Phosphorylation”, J. Biol. Chem., vol. 274, No. 28, 1999, pp. 19677-19685.
Jin et al., “Characterization of the Structure of a Low Km, Rolipram-sensitive cAMP Phosphodiesterase”, J. Biol. Chem., vol. 267, No. 26, 1992, pp. 18929-18939.
Kovala et al., “Recombinant Expression of a Type IV, cAMP-Specific Phosphodiesterase: Characterization and Structure-Function Studies of Deletion Mutants”, Biochemistry, vol. 36, No. 10, 1997, pp. 2968-2976.
Michaeli et al., “Isolation and Characterization of a Previously Undetected Human cAMP Phosphodiesterase by Complementation of cAMP Phosphodiesterase-deficientSaccharomyces cerevisiae”, J. Biol. Chem., vol. 268, No. 17, 1993, pp. 12925-12932.
Sonnenburg et al., “Identification of Inhibitory and Calmodulin-binding Domains of the PDE1A1 and PDE1A2 Calmodulin-stimulated Cyclic Nucleotide Phosphodiesterases”, J. Biol. Chem., vol. 270, No. 52, 1995, pp. 30989-31000.
Kenan et al., “Functions of the N-terminal Region of Cyclic Nucleotide Phosphodiesterase 3 (PDE 3) Isoforms”, J. Biol. Chem., vol. 275, No. 16, 2000, pp. 12331-12338.
Baehr et al., “Isolation and Characterization of cGMP Phosphodiesterase from Bovine Rod Outer Segments”, J. Biol. Chem., vol. 254, No. 22, 1979, pp. 11669-11677.
Beavo et al., “Hydrolysis of Cyclic Guanosine and Adenosine 3′,5′-Monophosphates by Rat and Bovine Tissues”, J. Biol. Chem., vol. 245, No. 21, 1970, pp. 5649-5655.
Bloom et al., “Identification and tissue-specific expression of PDE7 phosphodiesterase splice variants”, Proc. Natl. Acad. Sci. USA, vol. 93, 1996, pp. 14188-14192.
Fung et al., “Subunit stoichiometry of retinal rod cGMP phosphodiesterase”, Biochemistry, vol. 29, No. 11, 1990, pp. 2657-2664.
Gardner et al., “Cloning and Characterization of the Human and Mouse PDE7B, a Novel cAMP-Specific Cyclic Nucleotide Phosphodiesterase”, Biochem. Biophys. Res. Commun., vol. 272, 2000, pp. 186-192.
Han et al., “Alternative Splicing of the High Affinity cAMP-Specific Phosphodiesterase (PDE7A) mRNA in Human Skeletal Muscle and Heart”, J. Biol. Chem., vol. 272, No. 26, 1997, pp. 16152-16157.
Hoffmann et al., “Differential distribution of rat PDE-7 mRNA in embryonic and adult rat brain”, Cell Biochem. Biophys., vol. 28, Nos. 2-3, 1998, pp. 103-113.
Ichimura and Kase, “A New Cyclic Nucleotide Phosphodiesterase Isozyme Expressed in the T-Lymphocyte Cell Lines”, Bichem. Biophys. Res. Commun., vol. 193, No. 3, 1993, pp. 985-990.
Smith et al., “Hormone-sensitive Cyclic GMP-inhibited Cyclic AMP Phosphodiesterase in Rat Adipocytes”, J. Biol. Chem., vol. 266, No. 20, 1991, pp. 13385-13390.
Torphy et al., “Biochemical Characteristics and Cellular Regulation of Phosphodiesterase IV”, New Drugs in Allergy and Asthma, Agents & Actions Supplement vol. 43, 1993, pp. 51-71.

Affiliated with

Also associated with

Rating

Resorcinol derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Resorcinol derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Resorcinol derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3858722